-
Stocks to Watch: Jazz Pharmaceuticals plc – Ordinary Shares (NASDAQ:JAZZ), Ciber (NYSE:CBR), Furmanite Corporation (NYSE:FRM), Altisource Asset Management Corporation (NYSEMKT:AAMC)
Jazz Pharmaceuticals plc – Ordinary Shares (NASDAQ:JAZZ) in last trading activity moved down -3.39% to close at $182.99. Company weekly performance is -2.01% while its quarterly performance stands at 3.51%. Jazz Pharmaceuticals plc – Ordinary Shares (NASDAQ:JAZZ) is -3.93% away from its 52 week high. On April 23, Jazz Pharmaceuticals plc (NASDAQ:JAZZ) announced that it…
-
5 Stocks under Wall Street’s Radar: Jazz Pharmaceuticals (NASDAQ:JAZZ), Intel (NASDAQ:INTC), Alliant Energy (NYSE:LNT), International Business Machines (NYSE:IBM), RPC Inc. (NYSE:RES)
On Friday shares of Jazz Pharmaceuticals plc – Ordinary Shares (NASDAQ:JAZZ) closed at $189.42. Company’s sales growth for last 5 years was 55.60% and EPS growth for next 5 years is recorded as 19.67%. Analysts at Citigroup Inc. initiated coverage on shares of Jazz Pharmaceuticals plc – Ordinary Shares (NASDAQ:JAZZ) in a research report issued…
-
Trader’s Watch List: Sony Corp (NYSE:SNE), Jazz Pharmaceuticals (NASDAQ:JAZZ), Aegerion Pharmaceuticals (NASDAQ:AEGR), Telefonica Brasil, S.A. (NYSE:VIV), Tesla Motors Inc (NASDAQ:TSLA)
On last trading day Sony Corp (ADR) (NYSE:SNE) advanced 1.99% to close at $31.75. Its volatility for the week is 1.29% while volatility for the month is 1.30%. SNE’s sales growth for past 5 years was 0.10% and its EPS growth for past 5 years was -4.90%. Sony Corp (ADR) (NYSE:SNE) monthly performance is 22.97%.…
-
Whats Hot Today: Merck (NYSE:MRK), Jazz Pharmaceuticals (NASDAQ:JAZZ), The Goldman Sachs Group (NYSE:GS), Infoblox Inc. (NYSE:BLOX), Verizon Communications (NYSE:VZ)
Merck & Co. Inc. (NYSE:MRK) has 0.04% insider ownership while its institutional ownership stands at 75.40%. In last trading activity company’s stock closed at $57.43. Merck & Co. Inc. (NYSE:MRK) and partner Pfizer Inc. (PFE) announced that they have finalized an agreement to co-promote the latter’s anaplastic lymphoma kinase (ALK) inhibitor, Xalkori, for the treatment…
-
Why Making Dramatic Moves: Visa Inc. (NYSE:V), Jazz Pharmaceuticals plc (NASDAQ:JAZZ), Dow Chemical (NYSE:DOW), Google (NASDAQ:GOOG), Advanced Micro Devices (NASDAQ:AMD)
On Wednesday shares of Visa Inc. (NYSE:V) closed at $66.50. Company’s sales growth for last 5 years was 12.90% and EPS growth for next 5 years is recorded as 16.87%. Visa Inc. (NYSE:V) will report its fiscal second quarter 2015 financial results on Thursday, April 30, 2015. The results, along with accompanying financial information, will…
-
Stocks to Watch: Jazz Pharmaceuticals (NASDAQ:JAZZ), New Residential Investment Corp. (NYSE:NRZ), Cisco Systems (NASDAQ:CSCO), Olympic Steel Inc. (NASDAQ:ZEUS), Heartland Financial (NASDAQ:HTLF)
On Tuesday shares of Jazz Pharmaceuticals plc – Ordinary Shares (NASDAQ:JAZZ) closed at $168.77. Company’s sales growth for last 5 years was 55.60% and EPS growth for next 5 years is recorded as 19.60%. Citigroup Inc. began coverage on shares of Jazz Pharmaceuticals plc – Ordinary Shares (NASDAQ:JAZZ) in a report released on Friday. The…
-
Big Movers in Focus: Jazz Pharmaceuticals plc – Ordinary Shares (NASDAQ:JAZZ), 21Vianet Group (NASDAQ:VNET), RXi Pharmaceuticals (NASDAQ:RXII), BlackBerry (NASDAQ:BBRY), SLM Corporation (NASDAQ:SLM)
TheStreet upgraded shares of Jazz Pharmaceuticals plc – Ordinary Shares (NASDAQ:JAZZ) from a hold rating to a buy rating in a research report released on Tuesday morning. On Tuesday shares of Jazz Pharmaceuticals plc – Ordinary Shares (NASDAQ:JAZZ) closed at $169.99. Company’s sales growth for last 5 years was 55.60% and EPS growth for next…
-
Morning Alert: Jazz Pharmaceuticals plc – Ordinary Shares (NASDAQ:JAZZ), Office Depot (NASDAQ:ODP), Microsoft Corporation (NASDAQ:MSFT), ServiceNow (NYSE:NOW), Aerohive Networks (NYSE:HIVE)
On February 24, Jazz Pharmaceuticals plc – Ordinary Shares (NASDAQ:JAZZ) reported fourth-quarter net income of $81.6 million. The Dublin-based company said it had net income of $1.30 per share. Earnings, adjusted for amortization costs and stock option expense, came to $2.44 per share. On Friday shares of Jazz Pharmaceuticals plc – Ordinary Shares (NASDAQ:JAZZ) closed…
-
Mix Sector Stocks: Jazz Pharmaceuticals (NASDAQ:JAZZ), BIOLASE, (NASDAQ:BIOL), Starwood Waypoint Residential Trust (NYSE:SWAY), Verizon Communications (NYSE:VZ), Trina Solar (NYSE:TSL)
On February 25, Jazz Pharmaceuticals plc – Ordinary Shares (NASDAQ:JAZZ) reported fourth-quarter net income of $81.6 million. The Dublin-based company said it had net income of $1.30 per share. Earnings, adjusted for amortization costs and stock option expense, came to $2.44 per share. On Friday shares of Jazz Pharmaceuticals plc – Ordinary Shares (NASDAQ:JAZZ) closed…